Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia

• Main Authors: Yuancheng Chen (Author), Xiaojie Wu (Author), Chengyuan Tsai (Author), Liwen Chang (Author), Jicheng Yu (Author), Guoying Cao (Author), Beining Guo (Author), Yaoguo Shi (Author), Demei Zhu (Author), Fupin Hu (Author), Jinyi Yuan (Author), Yang Liu (Author), Xu Zhao (Author), Yingyuan Zhang (Author), Jufang Wu (Author), Jing Zhang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Nemonoxacin is an innovative quinolone antibiotic for treatment of community-acquired pneumonia (CAP). As more data are available from clinical studies, it is necessary to perform an integrative pharmacokinetic/pharmacodynamic (PK/PD) analysis to support and justify the optimal dosing...